辅助生殖技术和后代恶性瘤的风险:一个元分析
Linyu Zhang1,2, Gang Tang3, Xinrui Sun1,2
1Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
International journal of surgery (London, England)
|May 23, 2025
概括
辅助生殖技术 (ART) 不会增加后代的恶性瘤总体风险. 然而,ART可能与特定癌症 (如白血病和各种瘤) 的更高风险有关.
科学领域:
- 生殖医学 生殖医学
- 儿科瘤学 儿科瘤学
- 流行病学 流行病学
背景情况:
- 在全球范围内,辅助生殖技术 (ART) 的使用正在增加.
- 人们对通过ART怀孕的儿童潜在的长期健康风险,包括恶性瘤存在担忧.
- 以前对ART和后代癌症风险的研究产生了有争议的结果.
研究的目的:
- 系统评估辅助生殖技术 (ART) 与后代恶性瘤风险之间的关联.
- 综合来自多项研究的证据,以澄清ART与儿童癌症之间的有争议的关系.
主要方法:
- 在主要数据库 (Embase,科学网,PubMed,Cochrane图书馆) 进行了系统的文献搜索.
- 分析了来自20个队列和4个病例控制研究的数据.
- 计算了几率比率 (OR) 和95%置信区间来评估恶性瘤风险.
主要成果:
- 与自然怀孕相比,通过ART怀孕的后代的恶性瘤总体风险没有显著增加 (OR,1.04).
- 亚组分析显示ART组中白血病 (OR,1.24) 软组织瘤 (OR,1.35),肝脏瘤 (OR,2.10) 和上皮瘤/黑色素瘤 (OR,1.50) 的风险增加.
- 对于淋巴瘤,视网膜母细胞瘤,中枢神经系统瘤,神经母细胞瘤,脏瘤,生殖细胞/阴茎瘤和胚胎瘤的风险没有显著差异.
结论:
- 辅助生殖技术 (ART) 与后代整体恶性瘤的风险增加无关.
- 在ART和特定癌症的高风险之间存在潜在的关联,包括白血病,软组织瘤,肝脏瘤,上皮瘤和黑色素瘤.
相关概念视频
Nondisjunction
4.1K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.1K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K


